The death of a young biathlete has refocused attention on hypoxic training masks, especially their cardiovascular effects, in ...

In this exciting video, we delve into the future of rising boxing star José "Rayo" Valenzuela as we explore potential ...

The trial’s primary efficacy endpoint is AF burden, which refers to the percentage of time a participant is in AF.

Analysts have set 12-month price targets for Orchestra BioMed Hldgs, revealing an average target of $14.5, a high estimate of ...

Discover why Edgewise Therapeutics, Inc. is rated Buy amid strong trial data, unique HCM treatment, and major 2026 catalysts. Click for this EWTX update.

A coroner has published a damning list of risks that could lead the deaths of women and their newborns across the country, ...

In this conversation, Wendy Kim, DNP, R.N., vice president & chief nursing officer of Henry Ford Central Market, shares how the system's virtual nursing program is reducing documentation burden, ...

AI and digital health devices should not be viewed as replacements for health care professionals, but as tools that can be ...

A new study led by a researcher at University College London (UCL) suggests that the anti-obesity drug semaglutide may reduce ...

India's External Affairs Minister Dr S Jaishankar, speaking in Paris, highlighted the growing depth and potential of India's engagement with Europe during the Weimar format meeting. Calling France ...

Our journalists reflect on their impact from 2025, from connecting to local history to detailing the Trump administration's ...

DNA Vibe launches SHINE, a national movement uniting recovery, performance, and community--based manufacturing to unlock human potential and deliver one million regenerative wearables to student ...